5 November 2018

Young Chemist in Industry 2018

Organised by:

SCI's Young Chemists' Panel

Stevenage, UK

Registration Closed

This event is no longer available for registration.

Synopsis

This meeting is of interest to industrial chemists to discover what their contemporaries are working on in other companies and other areas of research, but also for academic chemists who want to find out the different challenges and focus that working in an industrial setting offers. It also presents a superb opportunity for younger chemists to showcase their industrial research to an external audience. Prizes will be awarded for the best talk and runners-up. In addition, a lecture from a leading industrial chemist will conclude the proceedings.

Attendees

This meeting is aimed at chemists working in the pharmaceutical, biotechnology or agrochemical sector and would provide them with a unique opportunity to discover what their contemporaries do in other branches of the industry. The meeting would also appeal to graduates and post-graduates with a background in organic chemistry.

Programme

09.45		Registration and refreshments

10.15		Opening remarks

10.20		Highly potent and selective tumour targeting bicyclic peptides - a novel approach to cancer therapy Gemma Mudd, Bicycle Therapeutics

10.45		Developing fundamental understanding of processes using ReactIR and FBRM in manufacturing process development Hazmi Tajuddin, Syngenta

11.10		Refreshment break

11.40		The design and synthesis of bromodomain photoaffinity probes David Fallon, GlaxoSmithKline

12.05		Dissecting a trimer: characterisation of the equilibrium between a boroxine and its parent boronic acid Edward Eden-Rump, AstraZeneca

12.30		Small molecule mutant isocitrate dehydrogenase 1 (mIDH1) inhibitors for the treatment of cancer Rose Bardell-Cox, Evotec

12.55		Lunch and exhibition

13.45		Mechanism of the dehydrogenative phenothiazination of phenols Monalisa Goswami, SPARK904

14.10		Trends in seed enhancement; novel seed binder technology James Flavell, Croda

14.35		The challenges of developing a 'trivial' acid-mediated CBz deprotection for the commercial manufacture of an important pharmaceutical intermediate Lucy Jackson, AstraZeneca

15.00		Refreshment break

15.30		Targeting a chemical probe for the cats eye chromosome region, candidate 2(CECR2) bromodomain Simon Lucas, GlaxoSmithKline

15.55		Plenary Talk - Control in process development - evolution of the manufacturing route to vestipitant Richard Horan, GlaxoSmithKline

16.45		Prize giving followed by networking reception